SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Biomatter Raises $18 Million in Series A Funding

Biomatter says AstraZeneca, BASF and Sanofi are among more than 25 enterprise customers, and that it has delivered more than 50 custom enzymes.

Related stories